Annual Financial Report

Summary by AI ^BETAClose X

MYCELX Technologies Corporation has announced the mailing of its 2025 Annual Report to shareholders, following the release of its final results on May 7, 2026. The report is available on the company's website and at its headquarters. Additionally, the company's 2026 Annual Meeting is scheduled for September 17, 2026, at the offices of Cavendish Capital Markets Limited in London.

Disclaimer*

MyCelx Technologies Corporation

16 June 2026

MYCELX Technologies Corporation

("MYCELX" or the "Company") (AIM: MYX or MYXR)

Mailing of 2025 Annual Report

MYCELX Technologies Corporation ("MYCELX" or the "Company"), a leading provider of proprietary water treatment technology to the Oil and Gas industry, announces that, following the release on 7 May 2026 of the Company's Final Results for the year ended 31 December 2025, the 2025 Annual Report is today being mailed to shareholders.

Copies have been placed on the Company's website at www.mycelx.com. Copies will also be available free of charge from the Company's headquarters at 1650 International Court, Suite 100, Norcross, Georgia, USA 30093 for a period of at least one month.

Annual Meeting

The Company's 2026 Annual Meeting will be held at 2:00 p.m. (BST) on Thursday 17 September 2026 at the offices of Cavendish Capital Markets Limited, One Bartholomew Close, London, EC1A 7BL. The Notice of Annual Meeting will be mailed to Shareholders prior to the Annual Meeting.

For further information please contact:

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

Tel: +1 888 306 6843

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Giles Balleny / Callum Davidson / Elysia Bough (Corporate Finance

Harriet Ward (Corporate Broking)

Jasper Berry / Michael Johnson (Sales)

Tel: +44 20 7220 0500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END